Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: An acute and chronic study

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 5, 2011, Pages 769-775

  Sanmukhani, Jayesh ^a   Anovadiya, Ashish ^a   Tripathi, Chandrabhanu B ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Antidepressant; Curcumin; Forced swimming test (FST); Tail suspension test (TST)

Indexed keywords

BIOCURCUMIN; CURCUMIN; DOPAMINE; FLUOXETINE; IMIPRAMINE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLIMBING; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MOUSE; NONHUMAN; RAT; SWIMMING; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; FEMALE; MALE; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; WISTAR RAT;

ACUTE DISEASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HINDLIMB SUSPENSION; IMIPRAMINE; MALE; MICE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SWIMMING;

EID: 80054048330     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gupta A., Bahadur I., Gupta K.R., Bhugra D.: Indian J. Psychiatry 48, 251 (2006).
2. Ustun T.B., Ayuso-Mateos J.L., Chatterjie S., Mathers C., Murray C.J.: Br. J. Psychiatry 184, 386 (2004).
3. Akiskal H.S.: in Comprehensive Textbook of Psychiatry, Sadock B.J., Sadock V.A. Eds., p. 1284, Williams & Wilkins, Baltimore 2000.
4. Gaynes B.N., Rush A.J., Trivedi M.H., Wisniewski S.R., Spencer D., Fava M.: Cleve. Clin. J. Med. 75, 57 (2008).
5. Xia X., Cheng G., Pan Y.: J. Ethnopharmacol. 110, 356 (2007).
6. Motterlini R., Foresti R., Bassi R., Green CJ.: Free Radic. Biol. Med. 28, 1303 (2000).
7. Varalakshmi C., Ali A.M., Pardhasaradhi B.V., Srivastava R.M., Singh S., Khar A.: Int. Immunopharmacol. 8, 688 (2008).
8. Sharma R.A., Gescher A.J., Steward W.P.: Eur. J. Cancer 41, 1955 (2005).
9. Xu Y., Ku B., Cui L., Barish P.A., Foster T.C., Ogle W.O.: Brain Res. 1162, 9 (2007).
10. Tayyem R.F., Heath D.D., Al-Delaimy W.K., Rock C.L.: Nutr. Cancer 55, 126 (2006).
11. Ghosh M.N.: in Fundamentals of Experimental Pharmacology, p. 176, Scientific Book Agency, Calcutta 2008.
12. Dhingra D., Kumar V.: Indian J. Pharmacol. 40, 175 (2008).
13. Porsolt R.D., Bertin A., Jalfre M.: Arch. Int. Pharmacodyn. Ther. 229, 327 (1977).
14. Steru L., Chermat R., Thierry B., Simon P.: Psychopharmacology 85, 367 (1985).
15. Nomura S., Shimizu J., Kinjo M., Kametani H., Nakazawa T.: Eur. J. Pharmacol. 83, 171 (1982).
16. Yu Z.F., Kong L.D., Chen Y.: J. Ethnopharmacol. 83, 161 (2002).
17. Kulkarni S.K., Bhutani M.K., Bishnoi M.: Psychopharmacology 201, 435 (2008).
18. Rénéric J.P., Lucki I.: Psychopharmacology 136, 190 (1998).
19. Xu Y., Ku B.S., Yao H.Y.: Eur. J. Pharmacol. 518, 40 (2005).
20. Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B., Li X.J.: Eur. J. Pharmacol. 578, 43 (2008).
21. Sapolsky R.M.: Biol. Psychiatry 48, 755 (2000).
22. Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y. et al.: Biol. Psychiatry 45, 1085 (1999).
23. Miller A.H., Raison C.L.: Focus 6, 36 (2008).
24. Singh S., Aggarwal B.B.: J. Biol. Chem. 270, 24995 (1995).
25. Vogel H.G., Vogel W.H.: in Drug Discovery and Evaluation, Springer Publication, New York 2005.
26. Sunal R., Gumusel B., Kayaalp O.S.: Pharmacol. Biochem. Behav. 49, 891 (1994).
27. Antony B., Merina B., Iyer V.S., Judy S., Lennertz K., Joyal S.: Indian J. Pharm. Sci. 4, 445 (2008).
28. Artigas F.: CNS Drugs 4, 79 (1995).
29. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y. et al.: Anticancer Res. 21, 2895 (2001).